Assembly Bill A3741

2019-2020 Legislative Session

Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee

  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

multi-Sponsors

2019-A3741 (ACTIVE) - Details

See Senate Version of this Bill:
S4482
Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Amd §3343-a, Pub Health L
Versions Introduced in Other Legislative Sessions:
2015-2016: A10656
2017-2018: A2810, S4374
2021-2022: S6045
2023-2024: S3350

2019-A3741 (ACTIVE) - Summary

Requires practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry.

2019-A3741 (ACTIVE) - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   3741
 
                        2019-2020 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             January 31, 2019
                                ___________
 
 Introduced by M. of A. McDONALD, MOSLEY, GALEF, JOYNER, MONTESANO, MORI-
   NELLO,  CAHILL,  GOTTFRIED, RAIA, WOERNER, LAWRENCE, BLAKE, B. MILLER,
   STECK, OTIS, COLTON, ASHBY -- Multi-Sponsored by -- M. of A.  BLANKEN-
   BUSH,  BRAUNSTEIN,  CROUCH, GIGLIO, McDONOUGH, SIMON, THIELE, WALSH --
   read once and referred to the Committee on Health

 AN ACT to amend the public health law, in relation to requiring  practi-
   tioners  who administer naloxone or another overdose reversal agent to
   a patient in the case of a suspected or confirmed overdose  to  report
   the administration of the agent to the prescription monitoring program
   registry
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision 9 of section 3343-a of the public health law is
 renumbered subdivision 10 and a new subdivision 9 is added  to  read  as
 follows:
   9.  ADMINISTRATION  OF  OVERDOSE REVERSAL AGENTS. (A) ANY PRACTITIONER
 WHO ADMINISTERS NALOXONE OR ANOTHER OVERDOSE REVERSAL AGENT TO A PATIENT
 IN THE CASE OF A SUSPECTED OR CONFIRMED OVERDOSE SHALL REPORT THE ADMIN-
 ISTRATION OF THE AGENT TO THE PRESCRIPTION MONITORING  PROGRAM  REGISTRY
 WITHIN  SEVENTY-TWO  HOURS  OF ADMINISTRATION. SUCH REPORT SHALL CONTAIN
 THE FOLLOWING INFORMATION IF AVAILABLE: (I) THE  NAME  OF  THE  PATIENT;
 (II) THE ADDRESS OF THE PATIENT; (III) THE DATE OF BIRTH OF THE PATIENT;
 (IV)  THE TIME AND PLACE OF THE ADMINISTRATION OF THE AGENT; AND (V) THE
 IDENTITY OF THE PERSON WHO ADMINISTERED THE NALOXONE TO THE PATIENT.
   (B) ANY REPORT MADE PURSUANT TO THE TERMS OF THIS SUBDIVISION SHALL BE
 CONSIDERED TO BE MADE BY THE REPORTER IN THE COURSE OF HIS OR HER DUTIES
 AND SHALL BE DIRECTLY RELATED TO PATIENT CARE.
   § 2. This act shall take effect January 1, 2021.
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD00587-01-9

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.